A Study of LY4405094 in Healthy Participants and Participants With Alzheimer's Disease
Sponsored by Eli Lilly and Company
About this study
The purpose of this study is to see how safe LY4405094 is and to see how much and how quickly LY4405094 gets into the bloodstream. For healthy participants, the study also looks at how much LY4405094 gets into the fluid around the brain and lasts up to 13 weeks and will include a 4-day stay in the Clinical Research Unit (CRU). For participants with Alzheimer's Disease, the study will also look at levels of a specific Alzheimer's-related protein in the brain and will last up to 25 weeks and will include a 3-day stay in the CRU.
Where this study is enrolling (2)
- Call 386-366-6400
Fortrea Clinical Research Unit
Daytona Beach, Florida
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
- I'm interested
Accel Research Sites - NeuroStudies Clinical Research Unit
Decatur, Georgia
Who can participate
Inclusion criteria
- ✓Participants must meet eligibility criteria in the ATMP screening protocol before entry into the treatment study.
Exclusion criteria
- ✕Have known allergies to LY4405094, related compounds (including remternetug), or any components of the formulation, including LY4405094.
- ✕Have known allergic reactions to adhesive or hydrogels or a family history of adhesive skin allergies.
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.